Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · IEX Real-Time Price · USD
68.88
-0.84 (-1.20%)
May 20, 2024, 4:00 PM EDT - Market closed
Utah Medical Products Revenue
Utah Medical Products had revenue of $49.04M in the twelve months ending March 31, 2024, down -6.54% year-over-year. Revenue in the quarter ending March 31, 2024 was $11.34M, a -9.42% decrease year-over-year. In the year 2023, Utah Medical Products had annual revenue of $50.22M, a decrease of -3.93%.
Revenue (ttm)
$49.04M
Revenue Growth
-6.54%
P/S Ratio
4.96
Revenue / Employee
$290,201
Employees
169
Market Cap
243.04M USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 50.22M | -2.06M | -3.93% |
| Dec 31, 2022 | 52.28M | 3.23M | 6.58% |
| Dec 31, 2021 | 49.05M | 6.88M | 16.30% |
| Dec 31, 2020 | 42.18M | -4.73M | -10.08% |
| Dec 31, 2019 | 46.90M | 4.91M | 11.68% |
| Dec 31, 2018 | 42.00M | 584.00K | 1.41% |
| Dec 31, 2017 | 41.41M | 2.12M | 5.38% |
| Dec 31, 2016 | 39.30M | -859.00K | -2.14% |
| Dec 31, 2015 | 40.16M | -1.12M | -2.72% |
| Dec 31, 2014 | 41.28M | 785.00K | 1.94% |
| Dec 31, 2013 | 40.49M | -1.06M | -2.55% |
| Dec 31, 2012 | 41.55M | 3.69M | 9.75% |
| Dec 31, 2011 | 37.86M | 12.74M | 50.71% |
| Dec 31, 2010 | 25.12M | -795.00K | -3.07% |
| Dec 31, 2009 | 25.92M | -1.87M | -6.72% |
| Dec 31, 2008 | 27.78M | -720.00K | -2.53% |
| Dec 31, 2007 | 28.50M | -251.00K | -0.87% |
| Dec 31, 2006 | 28.75M | 1.06M | 3.83% |
| Dec 31, 2005 | 27.69M | 1.21M | 4.56% |
| Dec 31, 2004 | 26.49M | -652.00K | -2.40% |
| Dec 31, 2003 | 27.14M | -224.00K | -0.82% |
| Dec 31, 2002 | 27.36M | 407.00K | 1.51% |
| Dec 31, 2001 | 26.95M | -239.00K | -0.88% |
| Dec 31, 2000 | 27.19M | -2.25M | -7.65% |
| Dec 31, 1999 | 29.44M | 1.77M | 6.38% |
| Dec 31, 1998 | 27.68M | 3.41M | 14.03% |
| Dec 31, 1997 | 24.27M | -14.40M | -37.24% |
| Dec 31, 1996 | 38.67M | -3.37M | -8.00% |
| Dec 31, 1995 | 42.04M | - | - |
| Dec 31, 1994 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AngioDynamics | 324.01M |
| Coherus BioSciences | 301.87M |
| ChromaDex | 83.17M |
| 2seventy bio | 71.20M |
| EDAP TMS | 65.80M |
| uniQure | 19.00M |
| Century Therapeutics | 1.37M |
UTMD News
- 13 days ago - Utah Medical Products, Inc. Announces Quarterly Dividend - Accesswire
- 25 days ago - Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2024 - Accesswire
- 3 months ago - UTMD Reports Audited Year 2023 and Fourth Quarter Financial Performance - GlobeNewsWire
- 7 months ago - Utah Medical Products, Inc. Increases Regular Quarterly Dividend - Accesswire
- 7 months ago - UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2023 - GlobeNewsWire
- 9 months ago - UTMD Updates Status of Filshie Product Liability Lawsuits in the U.S. - Accesswire
- 10 months ago - UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2023 - GlobeNewsWire
- 1 year ago - Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2023 - GlobeNewsWire